Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charles River Laboratories Intl (CRL)
NYSE:CRL
Holding CRL?
Track your performance easily
See the Price Targets and Ratings of:
CRL Analyst Ratings
Hold
2 Buy
8 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CRL Stock 12 Month Forecast
Average Price Target
$213.40
▲(3.32% Upside)
| Highest Price Target$250.00 | Average Price Target$213.40 | Lowest Price Target$151.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Assigned
11/11/24
Morgan Stanley
Reiterated
11/08/24
Citi
Reiterated
11/07/24
Barclays
Reiterated
11/07/24
Evercore ISI
Assigned
11/07/24
Mizuho Securities
Reiterated
11/06/24
Robert W. Baird
Reiterated
11/06/24
Bank of America Securities
Reiterated
11/06/24
J.P. Morgan
Reiterated
11/06/24
CLSA
$167→$205
Buy
-0.75%
Downside
Upgraded
11/06/24
Charles River upgraded to Hold from Underperform at CLSACharles River upgraded to Hold from Underperform at CLSA
Goldman Sachs
$290→$250
Buy
21.04%
Upside
Reiterated
08/07/24
Charles River price target lowered to $250 from $290 at Goldman SachsCharles River price target lowered to $250 from $290 at Goldman Sachs
Deutsche Bank
$300→$240
Buy
16.20%
Upside
Assigned
08/07/24
Charles River price target lowered to $240 from $300 at Deutsche BankCharles River price target lowered to $240 from $300 at Deutsche Bank
Argus Research
―
Hold
―
Downgraded
06/28/24
Charles River downgraded to Hold from Buy at ArgusCharles River downgraded to Hold from Buy at Argus
Jefferies
$235→$226
Hold
9.42%
Upside
Assigned
05/09/24
Analysts Offer Insights on Healthcare Companies: Charles River Labs (NYSE: CRL), Plus Therapeutics (NASDAQ: PSTV) and Argenx Se (NASDAQ: ARGX)
Best Analysts Covering Charles River Labs
Which Analyst Should I Follow If I Want to Buy CRL and Sell After:
1 Month
xxx
Success Rate
10/13 ratings generated profit
Average Return
+2.34%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 76.92% of your transactions generating a profit, with an average return of +2.34% per trade.
3 Months
xxx
Success Rate
9/13 ratings generated profit
Average Return
+10.08%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +10.08% per trade.
1 Year
Success Rate
9/13 ratings generated profit
Average Return
+41.35%
reiterated a buy rating 8 days ago
Copying Dan Leonard's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +41.35% per trade.
2 Years
xxx
Success Rate
7/13 ratings generated profit
Average Return
+17.47%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 53.85% of your transactions generating a profit, with an average return of +17.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CRL Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
0
0
0
0
0
Buy
7
8
7
5
3
Hold
6
10
8
12
14
Sell
0
0
0
3
4
Strong Sell
0
0
0
0
0
total
13
18
15
20
21
Each month's total comprises the sum of three months' worth of ratings.
CRL Financial Forecast
CRL Stock Forecast FAQ
What is CRL’s average 12-month price target, according to analysts?
Based on analyst ratings, Charles River Laboratories Intl’s 12-month average price target is $213.40.
What is CRL’s upside potential, based on the analysts’ average price target?
Charles River Laboratories Intl has 3.32% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRL a Buy, Sell or Hold?
Charles River Laboratories Intl has a consensus rating of Hold which is based on 2 buy ratings, 8 hold ratings and 2 sell ratings.
What is Charles River Laboratories Intl’s price target?
The average price target for Charles River Laboratories Intl is $213.40. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $250.00 ,the lowest forecast is $151.00. The average price target represents 3.32% Increase from the current price of $206.54.
The highest analyst price target is $250.00 ,the lowest forecast is $151.00. The average price target represents 3.32% Increase from the current price of $206.54.
What do analysts say about Charles River Laboratories Intl?
Charles River Laboratories Intl’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of CRL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.